203 related articles for article (PubMed ID: 30700325)
1. Systematic analysis of NLMP suggests nuclear localization of RTK/MET kinases resemble cancer cell clearance.
Xie Y; Nurkesh AA; Ibragimova N; Zhanzak Z; Meyerbekova A; Alexeyeva Z; Yesbolatova A; Satayeva M; Mustafa A; Manarbek L; Maipas A; Altaikyzy A; Keneskhanova Z; Akbay B; Chen Z
J Exp Clin Cancer Res; 2019 Jan; 38(1):43. PubMed ID: 30700325
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between nuclear MET and SOX9/β-catenin correlates with castration-resistant prostate cancer.
Xie Y; Lu W; Liu S; Yang Q; Carver BS; Li E; Wang Y; Fazli L; Gleave M; Chen Z
Mol Endocrinol; 2014 Oct; 28(10):1629-39. PubMed ID: 25099011
[TBL] [Abstract][Full Text] [Related]
3. Nuclear MET requires ARF and is inhibited by carbon nanodots through binding to phospho-tyrosine in prostate cancer.
Xie Y; Fan H; Lu W; Yang Q; Nurkesh A; Yeleussizov T; Maipas A; Lu J; Manarbek L; Chen Z; Benassi E
Oncogene; 2019 Apr; 38(16):2967-2983. PubMed ID: 30568225
[TBL] [Abstract][Full Text] [Related]
4. Nuclear Met promotes hepatocellular carcinoma tumorigenesis and metastasis by upregulation of TAK1 and activation of NF-κB pathway.
Tey SK; Tse EYT; Mao X; Ko FCF; Wong AST; Lo RC; Ng IO; Yam JWP
Cancer Lett; 2017 Dec; 411():150-161. PubMed ID: 28989054
[TBL] [Abstract][Full Text] [Related]
5. nMET, A New Target in Recurrent Cancer.
Xie Y; Istayeva S; Chen Z; Tokay T; Zhumadilov Z; Wu D; Hortelano G; Zhang J
Curr Cancer Drug Targets; 2016; 16(7):572-8. PubMed ID: 26728040
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional activation of the Axl and PDGFR-α by c-Met through a ras- and Src-independent mechanism in human bladder cancer.
Yeh CY; Shin SM; Yeh HH; Wu TJ; Shin JW; Chang TY; Raghavaraju G; Lee CT; Chiang JH; Tseng VS; Lee YC; Shen CH; Chow NH; Liu HS
BMC Cancer; 2011 Apr; 11():139. PubMed ID: 21496277
[TBL] [Abstract][Full Text] [Related]
7. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
[TBL] [Abstract][Full Text] [Related]
8. Broad RTK-targeted therapy overcomes molecular heterogeneity-driven resistance to cetuximab via vectored immunoprophylaxis in colorectal cancer.
Hu S; Dai H; Li T; Tang Y; Fu W; Yuan Q; Wang F; Lv G; Lv Y; Fan X; Zhang S; Jin R; Shen Y; Lin F; Ye X; Ding M; Yang Y; Lei C
Cancer Lett; 2016 Nov; 382(1):32-43. PubMed ID: 27569653
[TBL] [Abstract][Full Text] [Related]
9. c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype.
Li Y; Li A; Glas M; Lal B; Ying M; Sang Y; Xia S; Trageser D; Guerrero-Cázares H; Eberhart CG; Quiñones-Hinojosa A; Scheffler B; Laterra J
Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9951-6. PubMed ID: 21628563
[TBL] [Abstract][Full Text] [Related]
10. Identification of short-form RON as a novel intrinsic resistance mechanism for anti-MET therapy in MET-positive gastric cancer.
Wu Z; Zhang Z; Ge X; Lin Y; Dai C; Chang J; Liu X; Geng R; Wang C; Chen H; Sun M; Guo W; Li J
Oncotarget; 2015 Dec; 6(38):40519-34. PubMed ID: 26528757
[TBL] [Abstract][Full Text] [Related]
11. Overexpression-mediated activation of MET in the Golgi promotes HER3/ERBB3 phosphorylation.
Frazier NM; Brand T; Gordan JD; Grandis J; Jura N
Oncogene; 2019 Mar; 38(11):1936-1950. PubMed ID: 30390071
[TBL] [Abstract][Full Text] [Related]
12. Nuclear receptor tyrosine kinase transport and functions in cancer.
Chen MK; Hsu JL; Hung MC
Adv Cancer Res; 2020; 147():59-107. PubMed ID: 32593407
[TBL] [Abstract][Full Text] [Related]
13. H
Chen MK; Du Y; Sun L; Hsu JL; Wang YH; Gao Y; Huang J; Hung MC
J Biol Chem; 2019 May; 294(21):8516-8528. PubMed ID: 30962283
[TBL] [Abstract][Full Text] [Related]
14. Regenerating islet-derived family member, 4 modulates multiple receptor tyrosine kinases and mediators of drug resistance in cancer.
Vanderlaag K; Wang W; Fayadat-Dilman L; Wagner J; Bald L; Grein J; Janatpour MJ
Int J Cancer; 2012 Mar; 130(6):1251-63. PubMed ID: 21445968
[TBL] [Abstract][Full Text] [Related]
15. Phytochemicals, withaferin A and carnosol, overcome pancreatic cancer stem cells as c-Met inhibitors.
Aliebrahimi S; Kouhsari SM; Arab SS; Shadboorestan A; Ostad SN
Biomed Pharmacother; 2018 Oct; 106():1527-1536. PubMed ID: 30119228
[TBL] [Abstract][Full Text] [Related]
16. RETRACTED: The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor.
Brand TM; Iida M; Corrigan KL; Braverman CM; Coan JP; Flanigan BG; Stein AP; Salgia R; Rolff J; Kimple RJ; Wheeler DL
Sci Signal; 2017 Jan; 10(460):. PubMed ID: 28049763
[TBL] [Abstract][Full Text] [Related]
17. RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative Breast Cancer.
Weng TH; Yao MY; Xu XM; Hu CY; Yao SH; Liu YZ; Wu ZG; Tang TM; Fu PF; Wang MH; Yao HP
Cancer Res Treat; 2020 Jul; 52(3):973-986. PubMed ID: 32324988
[TBL] [Abstract][Full Text] [Related]
18. Cell lines expressing recombinant transmembrane domain-activated receptor kinases as tools for drug discovery.
Weber H; Müller D; Müller M; Ortiz A; Birkle M; Umber S; Ketterer C; Siedentopf O; Feger D; Totzke F; Kubbutat M; Schaechtele C; Ballmer-Hofer K; Ehlert JE; Graeser R
J Biomol Screen; 2014 Dec; 19(10):1350-61. PubMed ID: 25260782
[TBL] [Abstract][Full Text] [Related]
19. Nuclear localized Akt enhances breast cancer stem-like cells through counter-regulation of p21(Waf1/Cip1) and p27(kip1).
Jain MV; Jangamreddy JR; Grabarek J; Schweizer F; Klonisch T; Cieślar-Pobuda A; Łos MJ
Cell Cycle; 2015; 14(13):2109-20. PubMed ID: 26030190
[TBL] [Abstract][Full Text] [Related]
20. Primary breast cancer cell culture yields intra-tumor heterogeneous subpopulations expressing exclusive patterns of receptor tyrosine kinases.
Esparza-López J; Ramos-Elías PA; Castro-Sánchez A; Rocha-Zavaleta L; Escobar-Arriaga E; Zentella-Dehesa A; León-Rodríguez E; Medina-Franco H; Ibarra-Sánchez Mde J
BMC Cancer; 2016 Sep; 16(1):740. PubMed ID: 27645148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
